Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


28.08.2017

1 Acta Cytol
2 Am J Pathol
3 Ann Oncol
1 Ann Surg Oncol
4 Anticancer Res
3 BMC Cancer
2 Br J Cancer
1 Breast Cancer
4 Breast Cancer Res
21 Breast Cancer Res Treat
2 Breast J
3 Cancer
2 Cancer Cell
2 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
2 Cancer Res
4 Clin Breast Cancer
2 Clin Cancer Res
4 Eur J Cancer
1 Eur Radiol
2 Exp Cell Res
1 Int J Cancer
4 Int J Radiat Oncol Biol Phys
2 J Clin Invest
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Pathol
1 J Surg Oncol
1 JAMA
1 Lancet
2 Lancet Oncol
5 N Engl J Med
2 Nat Rev Clin Oncol
1 NPJ Breast Cancer
1 Oncogene
1 Pathology
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. TANI E, Fuentes-Martinez N, Skoog L
    A Review of the Use of Fine-Needle Aspiration Biopsy of Mammary Tumors for Diagnosis and Research.
    Acta Cytol. 2017;61.
    PubMed     Text format     Abstract available


    Am J Pathol

  2. COLEMAN WB
    Next-Generation Breast Cancer Omics.
    Am J Pathol. 2017 Aug 16. pii: S0002-9440(17)30716.
    PubMed     Text format     Abstract available

  3. COLEMAN WB, Anders CK
    Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures.
    Am J Pathol. 2017 Aug 16. pii: S0002-9440(17)30680.
    PubMed     Text format     Abstract available


    Ann Oncol

  4. GERMA C, Miller M, Mukhopadhyay P, Hewes B, et al
    Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib.
    Ann Oncol. 2017;28:2021-2024.
    PubMed     Text format    

  5. CURIGLIANO G, Burstein HJ, P Winer E, Gnant M, et al
    De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
    Ann Oncol. 2017;28:1700-1712.
    PubMed     Text format     Abstract available

  6. DEL MASTRO L, Lambertini M
    Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?
    Ann Oncol. 2017;28:1683-1685.
    PubMed     Text format    


    Ann Surg Oncol

  7. BERGQUIST JR, Murphy BL, Storlie CB, Habermann EB, et al
    Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2017 Aug 21. doi: 10.1245/s10434-017-6010.
    PubMed     Text format     Abstract available


    Anticancer Res

  8. NEUHAUSEN SL, Shani H, Boker LK, Steele L, et al
    Primary Peritoneal Serous Carcinoma in Men: A Rare and Non-BRCA-associated Entity.
    Anticancer Res. 2017;37:3069-3072.
    PubMed     Text format     Abstract available

  9. KONDO H, Shimono Y, Mukohyama J, Tanaka Y, et al
    Discordance of MCM7 mRNA and its Intronic MicroRNA Levels Under Hypoxia.
    Anticancer Res. 2017;37:3885-3890.
    PubMed     Text format     Abstract available

  10. KOBAYASHI H, Hamasaki M, Morishita T, Inoue T, et al
    Analysis of Evolving Clinicopathological Features of Metastatic Brain Tumors Over 30 Years of Surgical Management.
    Anticancer Res. 2017;37:3969-3974.
    PubMed     Text format     Abstract available

  11. SOBKOWICZ AD, Sanders AJ, Mason MD, Jiang WG, et al
    Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment.
    Anticancer Res. 2017;37:4255-4268.
    PubMed     Text format     Abstract available


    BMC Cancer

  12. ANDERSEN ZJ, Jorgensen JT, Gron R, Brauner EV, et al
    Active smoking and risk of breast cancer in a Danish nurse cohort study.
    BMC Cancer. 2017;17:556.
    PubMed     Text format     Abstract available

  13. CHEN K, Liu J, Li S, Jacobs L, et al
    Development of nomograms to predict axillary lymph node status in breast cancer patients.
    BMC Cancer. 2017;17:561.
    PubMed     Text format     Abstract available

  14. DUMA MN, Munch S, Oechsner M, Combs SE, et al
    Are heart toxicities in breast cancer patients important for radiation oncologists? A practice pattern survey in German speaking countries.
    BMC Cancer. 2017;17:563.
    PubMed     Text format     Abstract available


    Br J Cancer

  15. VAN MAAREN MC, Bretveld RW, Jobsen JJ, Veenstra RK, et al
    The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.
    Br J Cancer. 2017;117:179-188.
    PubMed     Text format     Abstract available

  16. ALESKANDARANY MA, Sonbul S, Surridge R, Mukherjee A, et al
    Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
    Br J Cancer. 2017 Aug 22. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Breast Cancer

  17. YANG J, Tang S, Zhou Y, Qiu J, et al
    Prognostic implication of the primary tumor location in early-stage breast cancer: focus on lower inner zone.
    Breast Cancer. 2017 Aug 18. doi: 10.1007/s12282-017-0797.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  18. ARANGO NP, Yuca E, Zhao M, Evans KW, et al
    Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer.
    Breast Cancer Res. 2017;19:93.
    PubMed     Text format     Abstract available

  19. CURTIT E, Pivot X, Henriques J, Paget-Bailly S, et al
    Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
    Breast Cancer Res. 2017;19:98.
    PubMed     Text format     Abstract available

  20. KERLIKOWSKE K, Ma L, Scott CG, Mahmoudzadeh AP, et al
    Combining quantitative and qualitative breast density measures to assess breast cancer risk.
    Breast Cancer Res. 2017;19:97.
    PubMed     Text format     Abstract available

  21. STURGEON SR, Pilsner JR, Arcaro KF, Ikuma K, et al
    White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Breast Cancer Res. 2017;19:94.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  22. BLAES A, Beckwith H, Florea N, Hebbel R, et al
    Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study.
    Breast Cancer Res Treat. 2017 Aug 11. doi: 10.1007/s10549-017-4447.
    PubMed     Text format     Abstract available

  23. LODI M, Scheer L, Reix N, Heitz D, et al
    Breast cancer in elderly women and altered clinico-pathological characteristics: a systematic review.
    Breast Cancer Res Treat. 2017 Aug 12. doi: 10.1007/s10549-017-4448.
    PubMed     Text format     Abstract available

  24. NEIL-SZTRAMKO SE, Boyle T, Milosevic E, Nugent SF, et al
    Does obesity modify the relationship between physical activity and breast cancer risk?
    Breast Cancer Res Treat. 2017 Aug 12. doi: 10.1007/s10549-017-4449.
    PubMed     Text format     Abstract available

  25. NATHAN S, Ma Y, Tomita YA, De Oliveira E, et al
    BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-alpha occupancy in the IKKB promoter and inhibits NF-kappaB activity in antiestrogen-resistant human breast cancer cells.
    Breast Cancer Res Treat. 2017 Aug 14. doi: 10.1007/s10549-017-4442.
    PubMed     Text format     Abstract available

  26. JACKLYN G, McGeechan K, Irwig L, Houssami N, et al
    Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
    Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4443.
    PubMed     Text format     Abstract available

  27. BONOFIGLIO D, Gabriele S, Aquila S, Qi H, et al
    Erratum to: Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells.
    Breast Cancer Res Treat. 2017 Aug 18. doi: 10.1007/s10549-017-4456.
    PubMed     Text format    

  28. ZHANG K, Zhou J, Zhu X, Luo M, et al
    Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.
    Breast Cancer Res Treat. 2017 Aug 20. doi: 10.1007/s10549-017-4425.
    PubMed     Text format     Abstract available

  29. KAUFMAN DI, Shah C, Vicini FA, Rizzi M, et al
    Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Breast Cancer Res Treat. 2017 Aug 22. doi: 10.1007/s10549-017-4451.
    PubMed     Text format     Abstract available

  30. FRISK G, Tinge B, Ekberg S, Eloranta S, et al
    Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy.
    Breast Cancer Res Treat. 2017 Aug 22. doi: 10.1007/s10549-017-4466.
    PubMed     Text format     Abstract available

  31. RYU JM, Yu J, Kim SI, Kim KS, et al
    Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.
    Breast Cancer Res Treat. 2017 Aug 22. doi: 10.1007/s10549-017-4472.
    PubMed     Text format     Abstract available

  32. HARANO K, Kogawa T, Wu J, Yuan Y, et al
    Thrombocytosis as a prognostic factor in inflammatory breast cancer.
    Breast Cancer Res Treat. 2017 Aug 22. doi: 10.1007/s10549-017-4463.
    PubMed     Text format     Abstract available

  33. REINER AS, Navi BB, DeAngelis LM, Panageas KS, et al
    Increased risk of arterial thromboembolism in older men with breast cancer.
    Breast Cancer Res Treat. 2017 Aug 23. doi: 10.1007/s10549-017-4433.
    PubMed     Text format     Abstract available

  34. ZHENG G, Yu H, Hemminki A, Forsti A, et al
    Familial associations of male breast cancer with other cancers.
    Breast Cancer Res Treat. 2017 Aug 23. doi: 10.1007/s10549-017-4468.
    PubMed     Text format     Abstract available

  35. LI J, Li H, Makunin I, Thompson BA, et al
    Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.
    Breast Cancer Res Treat. 2017 Aug 24. doi: 10.1007/s10549-017-4469.
    PubMed     Text format     Abstract available

  36. DIABY V, Ali AA, Williams KJ, Ezendu K, et al
    Economic evaluation of sequencing strategies in HER2-positive metastatic breast cancer in Mexico: a contrast between public and private payer perspectives.
    Breast Cancer Res Treat. 2017 Aug 24. doi: 10.1007/s10549-017-4473.
    PubMed     Text format     Abstract available

  37. DONG Y, Li T, Churilla TM, Shaikh T, et al
    Impact of rheumatoid arthritis on radiation-related toxicity and cosmesis in breast cancer patients: a contemporary matched-pair analysis.
    Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4438.
    PubMed     Text format     Abstract available

  38. HACK CC, Emons J, Jud SM, Heusinger K, et al
    Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.
    Breast Cancer Res Treat. 2017 Aug 21. doi: 10.1007/s10549-017-4446.
    PubMed     Text format     Abstract available

  39. NARAYAN A, Lebron-Zapata L, Morris E
    Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey.
    Breast Cancer Res Treat. 2017 Aug 21. doi: 10.1007/s10549-017-4461.
    PubMed     Text format     Abstract available

  40. CHOI HD, Chang MJ
    Cardiac toxicities of lapatinib in patients with breast cancer and other HER2-positive cancers: a meta-analysis.
    Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4460.
    PubMed     Text format     Abstract available

  41. HILL DA, Barry M, Wiggins C, Nibbe A, et al
    Estrogen receptor quantitative measures and breast cancer survival.
    Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4439.
    PubMed     Text format     Abstract available

  42. HOPKINS JO, Allred J, Hurria A, Jatoi A, et al
    Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302).
    Breast Cancer Res Treat. 2017 Aug 20. doi: 10.1007/s10549-017-4454.
    PubMed     Text format     Abstract available


    Breast J

  43. OKINES A, Irfan T, Khabra K, Smith I, et al
    Development and responses of brain metastases during treatment with trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer: A single institution experience.
    Breast J. 2017 Aug 22. doi: 10.1111/tbj.12906.
    PubMed     Text format     Abstract available

  44. MARCON M, Dedes K, Varga Z, Frauenfelder T, et al
    Influence of breast cancer opportunistic screening on aesthetic surgical outcome: A single-center retrospective study in Switzerland.
    Breast J. 2017 Aug 18. doi: 10.1111/tbj.12883.
    PubMed     Text format     Abstract available


    Cancer

  45. HAWLEY ST, Griffith KA, Hamilton AS, Ward KC, et al
    The association between patient attitudes and values and the strength of consideration for contralateral prophylactic mastectomy in a population-based sample of breast cancer patients.
    Cancer. 2017 Aug 15. doi: 10.1002/cncr.30924.
    PubMed     Text format     Abstract available

  46. BRAWLEY OW
    On assessing the effect of breast cancer screening schemes.
    Cancer. 2017 Aug 21. doi: 10.1002/cncr.30840.
    PubMed     Text format    

  47. SENNERSTAM RB, Franzen BSH, Wiksell HOT, Auer GU, et al
    Core-needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNA biopsy.
    Cancer. 2017 Aug 24. doi: 10.1002/cncy.21909.
    PubMed     Text format     Abstract available


    Cancer Cell

  48. YATES LR, Knappskog S, Wedge D, Farmery JHR, et al
    Genomic Evolution of Breast Cancer Metastasis and Relapse.
    Cancer Cell. 2017;32:169-184.
    PubMed     Text format     Abstract available

  49. ZHAO X, Powers S
    New Views into the Genetic Landscape of Metastatic Breast Cancer.
    Cancer Cell. 2017;32:131-133.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  50. O'BRIEN KM, Sandler DP, Kinyamu HK, Taylor JA, et al
    Single nucleotide polymorphisms in vitamin D-related genes may modify vitamin D-breast cancer associations.
    Cancer Epidemiol Biomarkers Prev. 2017 Aug 22. pii: cebp.0250.2017.
    PubMed     Text format     Abstract available

  51. CHEN L, Chubak J, Boudreau DM, Barlow WE, et al
    Use of antihypertensive medications and risk of adverse breast cancer outcomes in a SEER-Medicare population.
    Cancer Epidemiol Biomarkers Prev. 2017 Aug 14. pii: cebp.0346.2017.
    PubMed     Text format     Abstract available


    Cancer Lett

  52. AMUNJELA JN, Tucker SJ
    POPDC1 is suppressed in human breast cancer tissues and is negatively regulated by EGFR in breast cancer cell lines.
    Cancer Lett. 2017;406:81-92.
    PubMed     Text format     Abstract available


    Cancer Res

  53. LI J, Gao Z, Zhao D, Zhang L, et al
    PI-273, a substrate-competitive, specific small molecule inhibitor of PI4KIIalpha, inhibits the growth of breast cancer cells.
    Cancer Res. 2017 Aug 21. pii: canres.0484.2017.
    PubMed     Text format     Abstract available

  54. SAHNI JM, Gayle SS, Webb B, Weber-Bonk KL, et al
    Mitotic vulnerability in triple-negative breast cancer associated with LIN9 is targetable with BET inhibitors.
    Cancer Res. 2017 Aug 14. pii: canres.1571.2017.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  55. THAKUR KK, Bordoloi D, Kunnumakkara AB
    Alarming Burden of Triple-negative Breast Cancer in India.
    Clin Breast Cancer. 2017 Jul 20. pii: S1526-8209(17)30160.
    PubMed     Text format     Abstract available

  56. BASELGA J, Zamagni C, Gomez P, Bermejo B, et al
    RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2017 May 22. pii: S1526-8209(17)30005.
    PubMed     Text format     Abstract available

  57. FU J, Wu L, Fu W, Tan Y, et al
    How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
    Clin Breast Cancer. 2017 Jun 8. pii: S1526-8209(17)30033.
    PubMed     Text format     Abstract available

  58. LI L, Pan Z
    Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A Meta-Analysis of 37 Trials.
    Clin Breast Cancer. 2017 Jul 25. pii: S1526-8209(16)30358.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  59. SABBAGHI M, Gil-Gomez G, Guardia C, Servitja S, et al
    Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer.
    Clin Cancer Res. 2017 Aug 18. pii: clincanres.0696.2017.
    PubMed     Text format     Abstract available

  60. EMENS LA
    Breast Cancer Immunotherapy: Facts and Hopes.
    Clin Cancer Res. 2017 Aug 11. pii: clincanres.3001.2017.
    PubMed     Text format     Abstract available


    Eur J Cancer

  61. VRIENS IJH, Keymeulen K, Lobbes MBI, van Bommel ACM, et al
    Breast magnetic resonance imaging use in patients undergoing neoadjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers.
    Eur J Cancer. 2017;81:74-80.
    PubMed     Text format     Abstract available

  62. FOCKE CM, Burger H, van Diest PJ, Finsterbusch K, et al
    Interlaboratory variability of Ki67 staining in breast cancer.
    Eur J Cancer. 2017;84:219-227.
    PubMed     Text format     Abstract available

  63. BARTLETT JMS, Ahmed I, Regan MM, Sestak I, et al
    HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2.
    Eur J Cancer. 2017;79:129-138.
    PubMed     Text format     Abstract available

  64. PETRELLI F, Ghidini M, Lonati V, Tomasello G, et al
    The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis.
    Eur J Cancer. 2017;84:141-148.
    PubMed     Text format     Abstract available


    Eur Radiol

  65. DONG Y, Feng Q, Yang W, Lu Z, et al
    Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI.
    Eur Radiol. 2017 Aug 21. doi: 10.1007/s00330-017-5005.
    PubMed     Text format     Abstract available


    Exp Cell Res

  66. XIANG Y, Liao XH, Yao A, Qin H, et al
    MRTF-A-miR-206-WDR1 form feedback loop to regulate breast cancer cell migration.
    Exp Cell Res. 2017 Aug 17. pii: S0014-4827(17)30434.
    PubMed     Text format     Abstract available

  67. YAN N, Xu L, Wu X, Zhang L, et al
    GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
    Exp Cell Res. 2017 Aug 18. pii: S0014-4827(17)30435.
    PubMed     Text format     Abstract available


    Int J Cancer

  68. ZHENG G, Yu H, Hemminki A, Forsti A, et al
    Familial associations of female breast cancer with other cancers.
    Int J Cancer. 2017 Aug 12. doi: 10.1002/ijc.30927.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  69. LO Q, Hee L, Batumalai V, Allman C, et al
    Strain Imaging Detects Dose-Dependent Segmental Cardiac Dysfunction in the Acute Phase After Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2017;99:182-190.
    PubMed     Text format     Abstract available

  70. LEONARDI MC, Maisonneuve P, Mastropasqua MG, Cattani F, et al
    Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
    Int J Radiat Oncol Biol Phys. 2017;99:173-181.
    PubMed     Text format     Abstract available

  71. ARTHUR DW, Winter KA, Kuerer HM, Haffty BG, et al
    NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence.
    Int J Radiat Oncol Biol Phys. 2017;98:1028-1035.
    PubMed     Text format     Abstract available

  72. ROSSETTI A, Chadha M, Torres BN, Lee JK, et al
    The Impact of Music Therapy on Anxiety in Cancer Patients Undergoing Simulation for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:103-110.
    PubMed     Text format     Abstract available


    J Clin Invest

  73. TAYLOR NA, Vick SC, Iglesia MD, Brickey WJ, et al
    Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
    J Clin Invest. 2017 Aug 21. pii: 90499. doi: 10.1172/JCI90499.
    PubMed     Text format     Abstract available

  74. LI W, Zhang Z, Liu X, Cheng X, et al
    The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.
    J Clin Invest. 2017 Aug 14. pii: 94233. doi: 10.1172/JCI94233.
    PubMed     Text format     Abstract available


    J Clin Oncol

  75. KUIJER A, Straver M, den Dekker B, van Bommel ACM, et al
    Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study.
    J Clin Oncol. 2017;35:2814-2819.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  76. SINDZINSKI A
    Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    J Pathol

  77. ZHAO XL, Lin Y, Jiang J, Tang Z, et al
    HMGB1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells.
    J Pathol. 2017 Aug 12. doi: 10.1002/path.4958.
    PubMed     Text format     Abstract available


    J Surg Oncol

  78. YANG EJ, Kwon Y
    Changes in shoulder muscle activity pattern on surface electromyography after breast cancer surgery.
    J Surg Oncol. 2017 Aug 22. doi: 10.1002/jso.24800.
    PubMed     Text format     Abstract available


    JAMA

  79. SLOMSKI A
    Olaparib Increased Survival in Metastatic Breast Cancer.
    JAMA. 2017;318:690.
    PubMed     Text format    


    Lancet

  80. MAMOUNAS EP, Kuehn T, Rutgers EJT, von Minckwitz G, et al
    Current approach of the axilla in patients with early-stage breast cancer.
    Lancet. 2017 Aug 14. pii: S0140-6736(17)31451.
    PubMed     Text format     Abstract available


    Lancet Oncol

  81. KIM SB, Dent R, Im SA, Espie M, et al
    Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Oncol. 2017 Aug 8. pii: S1470-2045(17)30450.
    PubMed     Text format     Abstract available

  82. DELALOGE S, DeForceville L
    Targeting PI3K/AKT pathway in triple-negative breast cancer.
    Lancet Oncol. 2017 Aug 8. pii: S1470-2045(17)30514.
    PubMed     Text format    


    N Engl J Med


  83. More on Co-Occurrence of COMT and BRCA1/2 Variants in a Population.
    N Engl J Med. 2017;377:795-6.
    PubMed     Text format    


  84. Adjuvant Capecitabine for Breast Cancer.
    N Engl J Med. 2017;377:791-2.
    PubMed     Text format    

  85. HIZAL M, Sendur MAN, Yalcin B
    Adjuvant Capecitabine for Breast Cancer.
    N Engl J Med. 2017;377:791.
    PubMed     Text format    

  86. RUADES NINFEA JI, Burdette-Radoux S, Wood ME
    Adjuvant Capecitabine for Breast Cancer.
    N Engl J Med. 2017;377:790-1.
    PubMed     Text format    

  87. SPURDLE AB, Goldgar DE, Easton DF
    More on Co-Occurrence of COMT and BRCA1/2 Variants in a Population.
    N Engl J Med. 2017;377:795.
    PubMed     Text format    


    Nat Rev Clin Oncol

  88. SIDAWAY P
    Breast cancer: Brain metastasis detectable in CTCs.
    Nat Rev Clin Oncol. 2017 Aug 22. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    

  89. SIDAWAY P
    Breast cancer: 10-year follow-up of the TEAM cohort reported.
    Nat Rev Clin Oncol. 2017 Aug 16. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


    NPJ Breast Cancer

  90. SPEERS C, Zhao SG, Chandler B, Liu M, et al
    Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.
    NPJ Breast Cancer. 2017;3:29.
    PubMed     Text format     Abstract available


    Oncogene

  91. SU CM, Wang MY, Hong CC, Chen HA, et al
    miR-520h is crucial for DAPK2 regulation and breast cancer progression.
    Oncogene. 2017 Aug 21. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Pathology

  92. CHOI JS, Kim KH, Oh E, Shin YK, et al
    Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
    Pathology. 2017 Aug 14. pii: S0031-3025(17)30144.
    PubMed     Text format     Abstract available


    PLoS One

  93. TANG C, Wang P, Li X, Zhao B, et al
    Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
    PLoS One. 2017;12:e0182953.
    PubMed     Text format     Abstract available

  94. CASTELLANO I, Metovic J, Balmativola D, Annaratone L, et al
    The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients.
    PLoS One. 2017;12:e0182073.
    PubMed     Text format     Abstract available

  95. MA S, Dielschneider RF, Henson ES, Xiao W, et al
    Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells.
    PLoS One. 2017;12:e0182921.
    PubMed     Text format     Abstract available

  96. WANG J, Kong X, Xing Z, Wang X, et al
    A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?
    PLoS One. 2017;12:e0183012.
    PubMed     Text format     Abstract available

  97. YTTERSIAN SLETTA K, Tveitaras MK, Lu N, Engelsen AST, et al
    Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts.
    PLoS One. 2017;12:e0183254.
    PubMed     Text format     Abstract available

  98. HOSOKAWA Y, Masaki N, Takei S, Horikawa M, et al
    Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
    PLoS One. 2017;12:e0183724.
    PubMed     Text format     Abstract available

  99. LI M, Chen K, Liu F, Su F, et al
    Nipple sparing mastectomy in breast cancer patients and long-term survival outcomes: An analysis of the SEER database.
    PLoS One. 2017;12:e0183448.
    PubMed     Text format     Abstract available

  100. CHIEN TJ, Hsu CH, Liu CY, Fang CJ, et al
    Effect of acupuncture on hot flush and menopause symptoms in breast cancer- A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180918.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: